Analysis of synthetic cannabinoids in abstinence control: Long drug detection windows in serum and implications for practitioners

Drug Testing and Analysis

Volumn 6, Issue 1-2, 2014, Pages 135-136

  Kneisel, Stefan ^a,b   Teske, Jörg ^c   Auwärter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DETECTION WINDOWS; DRUG DETECTION; SYNTHETIC CANNABINOID;

CANNABINOID; DELTA9(11) TETRAHYDROCANNABINOL;

ABSTINENCE; DRUG ANALYSIS; DRUG DETERMINATION; DRUG USE; FOLLOW UP; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

CANNABINOIDS; HUMANS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84892459043     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1445     Document Type: Letter

References (10)

1. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirós. 'Spice' and other herbal blends: Harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
2. M.B. Forrester, K. Kleinschmidt, E. Schwarz, A. Young. Synthetic cannabinoid exposures reported to Texas Poison Centers. J. Addict. Dis. 2011, 30, 351.
3. M. Hermanns-Clausen, S. Kneisel, B. Szabo, V. Auwärter. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: Clinical and laboratory findings. Addiction 2012. DOI: 10.1111/j.1360-0443.2012.04078.x
4. S. Every-Palmer. Warning: Legal Synthetic cannabinoid-receptor agonists such as JWH-018 May precipitate psychosis in vulnerable individuals. Addiction 2010, 105, 1859.
5. S. Every-Palmer. Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug Alcohol Depend. 2011, 117, 152.
6. J. Teske, J.-P. Weller, A. Fieguth, T. Rothämel, Y. Schulz, H.D. Tröger. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878, 2659.
7. S.L. Kacinko, A. Xu, J.W. Homan, M.M. McMullin, D.M. Warrington, B.K. Logan. Development and validation of a liquid chromatography-Tandem Mass Spectrometry Method for the Identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J. Anal. Toxicol. 2011, 35, 386.
8. J. Ammann, J.M. McLaren, D. Gerostamoulos, J. Beyer. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids. J. Anal. Toxicol. 2012, 36, 372.
9. S. Kneisel, V. Auwärter. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47, 825.
10. E. Johansson, M.M. Halldin, S. Agurell, L.E. Hollister, H.K. Gillespie. Terminal elimination plasma half-life of Δ1-tetrahydrocannabinol (Δ1-THC) in heavy users of marijuana. Eur. J. Clin. Pharmacol. 1989, 37, 273.